AMVAC^® announces China distribution with Plant Health Care^®

Plant Health Care^® (AIM.PHC.L), a leading provider of peptides used by growers to improve crop production and quality within global agricultural markets, announced it has signed a distribution agreement (the ″Agreement″) with AMVAC^®, an American Vanguard Company, to support commercialization of novel fertilizer products in China. 

Highlights:

• AMVAC, through its subsidiary in China, will distribute a novel fertilizer product incorporating PHC’s Harpinαβ technology designed for use within vegetable and row crops to promote plant health and yield.

  
  

• AMVAC continues to evaluate PHC’s technology within other markets including Australia, Central America, and Brazil as novel products to deliver disease and nematode control in crops such as bananas, potatoes, and soybeans.

The Agreement will support commercial sales of the Harpinαβ technology in combination with a novel AMVAC fertilizer. The first AMVAC product launches to bring widespread availability of the Harpinαβ technology to growers in China will occur in 2024. This novel product will help growers improve crop quality and yield as part of an integrated and environmentally responsible crop production program.

Harpinαβ strengthens the innate immune defense systems common within all plants in a manner similar to vaccinations in humans, with crops responding with improved nutrient use efficiency, tolerance to abiotic stress and ultimately, increased yield, and crop quality. Relative to alternative biological products in the market, Harpinαβ-based products provide highly consistent product efficacy across a wide range of application and environmental conditions and is compatible with synthetic fertilizers, fungicides, herbicides, and insecticides commonly used within commercial agriculture.

Jeff Tweedy, CEO of Plant Health Care, said: ‟I am pleased to see our collaboration with AMVAC result in the launch of an innovative, new product in China. There is a tremendous opportunity in China for the adoption of Harpinαβ-based products to support sustainable agriculture. AMVAC has proven they have the right strategy and the right team in China to drive new product adoption. We are excited about the upcoming launch later this year. In the next few years, I fully expect additional products to emerge from the ongoing collaboration between our companies in China and other high-value markets.″

Lawrence Yu, AMVAC Head of Asia-Pacific Region, said: ″AMVAC looks forward to increasing our biological product offerings in China through this new partnership with Plant Health Care. We look forward to expanding other distribution opportunities globally, by utilizing AMVAC’s strong market access across its global footprint.″

Jim Thompson, Director of Business Development for GreenSolutions at AMVAC, added: ″The Harpinαβ-technology is a proven multi-crop solution that complements our GreenSolutions portfolio of biological and specialty nutrition products, which will provide our distribution partners and growers more flexibility and increased ROI.